A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

10.5K views

⸱

DOI:

10.3791/54124

⸱

July 20th, 2016

 , 

In This Article

Summary

The protocol described here represents an easy and reproducible method that employs reverse phase high-performance liquid chromatography (RP-HPLC) to measure purine metabolism on chronic lymphocytic leukemia (CLL) cells cultured under different conditions.

Abstract

This method describes a sensitive, specific, reliable and reproducible reverse phase high-performance liquid chromatography (RP-HPLC) assay developed and validated for the quantification of extracellular purine nucleotides and nucleosides produced by purified chronic lymphocytic leukemia (CLL) cells under different culture conditions. The chromatographic separation of adenosine 5'-monophosphate (AMP), adenosine (ADO) and inosine (INO) is performed at RT on a silica-based, reversed-phase column that is used for polar compound retention. The method includes a binary mobile phase, which consists of 7 mM ammonium acetate and acetonitrile with a flow rate of 1.00 ml/min. The eluates are monitored using a Photodiode Array UV detector set at 260 nm. A standard calibration curve is generated to calculate the equation for the analytical quantification of each purine compound. System control, data acquisition and analysis are then performed. Applying this protocol, AMP, INO and ADO elute at 7, 11 and 11.9 min, respectively, and the total run time for each sample is 20 min. This protocol may be applied to different cell types and cell lines (both suspension and adherent), using culture media as matrix. The advantages are easy and fast sample preparation and the requirement of a small amount of supernatant for analysis. Furthermore, the use of a serum-free medium allows skipping the protein precipitation step with acetonitrile that impacts the final concentration of purine compounds. One of the limitations of the method is the requirement of the equilibration column run before each single sample run, making the total run time of the experiment longer and preventing high throughput screening applications.

Introduction

Adenosine (ADO) is a purine nucleoside with an adenine molecule attached to a ribose sugar molecule moiety through a glycosidic bond. When present in the extracellular environment, it protects cells from excessive damage by the action of the immune system. This role has been highlighted using different disease models, such as colitis1, diabetes2, asthma3, sepsis4, and ischemic injury5. One of the main ADO functions is the inhibition of immune responses in the tumor microenvironment, contributing to tumor immune evasion6. For this reason, the mechanisms involved in ADO formation and signaling are of cons....

Access restricted. Please log in or start a trial to view this content.

Protocol

CLL blood samples are obtained in accordance with Institutional Guidelines and Declaration of Helsinki.

1. Isolation of Leukemic Lymphocytes from Blood Samples of CLL Patients 

  1. Collect blood sample in sodium heparin (green-top) tube17.
  2. Make 1: 3 dilution of whole blood with RT 1x phosphate buffered saline (PBS).
  3. Purify peripheral blood mononuclear cells (PBMC) from blood samples by density gradient centrifugation.
    1. Underlay 5 ml of density centrifugation media (e.g., Ficoll) in a 15 ml centrifuge tube and carefully transfer 10 ml of diluted blood. Immediately centrifuge at 1,500 x g for 20 min at RT....

Access restricted. Please log in or start a trial to view this content.

Results

To evaluate the percentage (%) of leukemic cells in freshly purified PBMCs from a representative CLL patient, cells are marked with anti-CD19 and anti-CD5 antibodies. The left panel of Figure 3 represents a cytofluorimetric dot plot with a selective gate on live cells. Figure 3 shows an example of PBMC from a CLL patient before (middle panel) and after (right panel) B cell purification.

An examp.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The protocol described here permits to evaluate the activity of the CD39/CD73 adenosinergic machinery in cell culture media from purified human leukemic cells. Through this HPLC method we can follow and quantitatively measure the enzymatic generation of ADO (CD73-dependent) and its subsequent degradation to INO (CD26/ADA dependent). The use of enzyme inhibitors allows to control the protocol and to have internal controls. The advantages and novelties of this protocol are that i) it may be applied to cells that are growin.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work is supported by Associazione Italiana Ricerca Cancro (IG #12754).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Human blood
Milli-Q waterMilliporedouble deionised water
Ficoll-Paque PlusGE-Healthcare17-1440-03
purified anti-CD3, -CD14, -CD16made in-housemouse monoclonal
PE-labeled anti-CD19Miltenyi Biotec120-014-229
FITC-labeled anti-CD5Miltenyi Biotec130-096-574
Dynabeads sheep anti-mouse IgGInvitrogen11031
Phosphate-buffered saline (PBS)AmrescoE404-200TABStablets
bovine serum albumin (BSA)ID bio1000-70standard grade
isolation bufferPBS 0.1% BSA 2 mM EDTA, pH 7.4
AIM V serum free mediumGIBCO12055-091liquid (research grade)
adenosine 5’-diphosphate (ADP)Sigma-AldrichA2754
adenosine 5’-monosphate (AMP)Sigma-AldrichA1752
adenosine (ADO)Sigma-AldrichA9251
inosine (INO)Sigma-AldrichI4125
α,β-methylene-ADP (APCP)Sigma-AldrichM8386CD73 inhibitor
EHNA hydrochlorideSigma-AldrichE114adenosine deaminase inhibitor
Deoxycoformycin (dCF)Tocris2033adenosine deaminase inhibitor
Dimethyl sulfoxide (DMSO)Sigma-AldrichD2650
DipyridamoleSigma-AldrichD9766nucleoside transporter inhibitor
acetonitrile (CHROMASOLV Plus)Sigma-Aldrich34998HPLC-grade
ammonium acetateSigma-Aldrich96887 mM, pH 3.0
hydrochloric acidSigma-Aldrich30721-1Lmin. 37%
NameCompanyCatalog NumberComments
Equipment
Bürker cell counterVWR631-0920hemocytometer
DynaMag-15 MagnetInvitrogen12301DDynal magnetic bead separator
microcentrifuge safe-lock tubesEppendorf030-120-00861.5 ml
PET centrifuge tubesCorning430053/43030415 – 50 ml
Minisart RC4 syringe filtersSartorius Stedim Biotech17821membrane 0.2 µm
short thread vialsVWR548-00291.5 ml/glass
micro-insertsVWR548-00060.1 ml/glass
screw capsVWR548-00859 mm/PP blue
Atlantis dC18 ColumnWaters1860013445 µm, 4.6 mm x 150 mm
Atlantis dC18 Guard ColumnWaters1860013235 µm, 4.6 mm x 20 mm
Waters Alliance 2965 Separations ModuleWatersHPLC separation module
Waters 2998 Photodiode Array (PDA) DetectorWatersUV detector
Waters Empower2 softwareWaters

References

  1. Naganuma, M., Wiznerowicz, E. B., Lappas, C. M., Linden, J., Worthington, M. T., Ernst, P. B. Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunology. 177 (5), 2765-2769 (2006).
  2. Nemeth, Z. H., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

HPLC AssayPurine MetabolismCLL CellsReverse Phase ChromatographyCell IsolationFlow CytometryStandard CalibrationEnzyme InhibitorsSerum Free Media